VITASPRING BIOMEDICAL CO., LTD. Long-term Investments and Receivables, Net
VITASPRING BIOMEDICAL CO., LTD. (VSBC) had Long-term Investments and Receivables, Net of $283.73 thousand as of 2022-10-31, per its 10-Q filed 2022-12-21.
Discontinued › Balance Sheet › Assets
us-gaap:LongTermInvestmentsAndReceivablesNet · last filed 2022-12-21
- 2022-10-31: Long-term Investments and Receivables, Net $283.73K.
- 2022-07-31: Long-term Investments and Receivables, Net $283.73K.
- 2022-04-30: Long-term Investments and Receivables, Net $419.55K.
- 2022-01-31: Long-term Investments and Receivables, Net $282.47K; Long-term Investments and Receivables, Net as first filed $463.57K.
| Period end | Long-term Investments and Receivables, Net | Long-term Investments and Receivables, Net as first filed |
|---|---|---|
| 2022-10-31 | $283.73K 10-Q · filed 2022-12-21 | |
| 2022-07-31 | $283.73K 10-Q · filed 2022-09-15 | |
| 2022-04-30 | $419.55K 10-Q · filed 2022-06-15 | |
| 2022-01-31 | $282.47K 10-Q · filed 2022-12-21 | $463.57K 10-K · filed 2022-05-03 |